These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 5220671)
21. Case report: a nineteen year study of Dilantin hyperplasia. Swenson HM Periodontal Case Rep; 1984; 6(1):31-3. PubMed ID: 6591228 [No Abstract] [Full Text] [Related]
22. Pilot study for a comparative electron microscope investigation of normal gingiva and diphenyl hydantoin induced hyperplastic gingiva. Erlank OA; Glassman J; Olivier B; Rider DJ; Wasserman T Diastema; 1982; 10():23-6. PubMed ID: 6959937 [No Abstract] [Full Text] [Related]
23. Effects of antihistaminic therapy on diphenylhydantoin sodium (dilantin) gingival hyperplasia. INGLE JI; HOWARD WL; ZWICK HH J Am Dent Assoc; 1959 Mar; 58(3):65-71. PubMed ID: 13630660 [No Abstract] [Full Text] [Related]
24. Dilantin gingival hyperplasia; report of a case. BLAKE H; BLAKE FS Oral Surg Oral Med Oral Pathol; 1953 Jul; 6(7):818-21. PubMed ID: 13073184 [No Abstract] [Full Text] [Related]
25. Management of excessive gingival display following adult orthodontic treatment: a case report. Landsberg CJ; Sarne O Pract Proced Aesthet Dent; 2006 Mar; 18(2):89-94; quiz 96, 122. PubMed ID: 16642792 [TBL] [Abstract][Full Text] [Related]
26. Subcellular distribution of oxidative enzymes in human, inflamed and dilantin hyperplastic gingiva. Fine AS; Scopp IW; Egnor R; Froum S; Thaler R; Stahl SS Arch Oral Biol; 1974 Jul; 19(7):565-71. PubMed ID: 4370410 [No Abstract] [Full Text] [Related]
31. The effect of prolonged phenytoin administration on non-collagenous components of gingival tissue. Goultschin J; Sofer B; Shoshan S Int J Tissue React; 1983; 5(2):227-30. PubMed ID: 6618788 [TBL] [Abstract][Full Text] [Related]
32. Effect of 5,5-diphenylhydantoin on a gingival hyperplasia development. Drízhal I; Spacek J; Hrdinová V; Lichý J; Kaut V Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(5):625-89. PubMed ID: 6972082 [No Abstract] [Full Text] [Related]
33. [Modified technic for the treatment of gingival hyperplasia in epileptic patients]. Yarkut E; Turgut E Istanbul Univ Dishekim Fak Derg; 1969 Jun; 3(2):151-68. PubMed ID: 5265430 [No Abstract] [Full Text] [Related]
34. Anesthetic and surgical considerations in children with dilantin gingival hyperplasia. Peeples GA J Oral Med; 1980; 35(4):97-8. PubMed ID: 6937610 [No Abstract] [Full Text] [Related]
36. Studies on dilantin hyperplastic gingivitis. The role of magnesium. Baer PN; Davis RK; Merrit AD J Dent Res; 1965; 44(5):1055. PubMed ID: 5213011 [No Abstract] [Full Text] [Related]
37. Incidence of phenytoin induced gingival overgrowth in epileptic children: a six month evaluation. Prasad VN; Chawla HS; Goyal A; Gauba K; Singhi P J Indian Soc Pedod Prev Dent; 2002 Jun; 20(2):73-80. PubMed ID: 12435021 [TBL] [Abstract][Full Text] [Related]
38. Antihistaminic therapy for gingival hyperplasia due to dilantin. GAILLARD RA N Engl J Med; 1957 Jan; 256(2):76-7. PubMed ID: 13388034 [No Abstract] [Full Text] [Related]
39. Gingival cryotherapy: a case report. Walker FE Chronicle; 1971 Mar; 34(7):181-2. PubMed ID: 5278609 [No Abstract] [Full Text] [Related]
40. Metabolism of phenytoin by the gingiva of normal humans: the possible role of reactive metabolites of phenytoin in the initiation of gingival hyperplasia. Zhou LX; Pihlstrom B; Hardwick JP; Park SS; Wrighton SA; Holtzman JL Clin Pharmacol Ther; 1996 Aug; 60(2):191-8. PubMed ID: 8823237 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]